Prolonged prophylaxis in orthopedic surgery: insights from the United States
Anderson, Frederick A. Jr. ; White, Kami
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
*Arthroplasty, Replacement, Hip
*Arthroplasty, Replacement, Knee
Bandages
Combined Modality Therapy
Drug Utilization
Female
Fibrinolytic Agents
Heparin, Low-Molecular-Weight
Humans
Male
Middle Aged
Postoperative Complications
Postoperative Period
Pulmonary Embolism
Registries
Thrombosis
United States
Health Services Research
Orthopedics
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
The U.S. Hip and Knee Registry is a voluntary national registry of outcome data for hip and knee surgery. In total, 469 orthopedic surgeons from 325 hospitals reported data on 7677 patients who underwent total hip arthroplasty (THA) and 11,461 patients who underwent total knee arthroplasty (TKA). Data on patients enrolled between 1996 and 2000 indicate that 40% of THA patients and 42% of TKA patients received prophylaxis for a period of 8 to 21 days, including the in-hospital period. Prolonged prophylaxis for more than 21 days was used in 49% of THA patients and 44% of TKA patients. Moreover, year on year, data indicate that the percentage of patients who receive prophylaxis for longer than 21 days is gradually increasing. In 2000, 53% of THA patients and 47% of TKA patients received prophylaxis for longer than 21 days.
Source
Semin Thromb Hemost. 2002 Aug;28 Suppl 3:43-6. Link to article on publisher's site